388 related articles for article (PubMed ID: 28644075)
1. Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations.
Bishop AJ; Tao R; Guadagnolo BA; Allen PK; Rebueno NC; Wang XA; Amini B; Tatsui CE; Rhines LD; Li J; Chang EL; Brown PD; Ghia AJ
J Neurosurg Spine; 2017 Sep; 27(3):303-311. PubMed ID: 28644075
[TBL] [Abstract][Full Text] [Related]
2. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
[TBL] [Abstract][Full Text] [Related]
3. Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence.
Bishop AJ; Tao R; Rebueno NC; Christensen EN; Allen PK; Wang XA; Amini B; Tannir NM; Tatsui CE; Rhines LD; Li J; Chang EL; Brown PD; Ghia AJ
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1016-1026. PubMed ID: 26025777
[TBL] [Abstract][Full Text] [Related]
4. The use of spine stereotactic radiosurgery for oligometastatic disease.
Ho JC; Tang C; Deegan BJ; Allen PK; Jonasch E; Amini B; Wang XA; Li J; Tatsui CE; Rhines LD; Brown PD; Ghia AJ
J Neurosurg Spine; 2016 Aug; 25(2):239-47. PubMed ID: 27035507
[TBL] [Abstract][Full Text] [Related]
5. Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk.
Shanker MD; Cavazos AP; Li J; Beckham TH; Yeboa DN; Wang C; McAleer MF; Briere TM; Amini B; Tatsui CE; North RY; Alvarez-Breckenridge CA; Cezayirli PC; Rhines LD; Ghia AJ; Bishop AJ
Radiother Oncol; 2024 Apr; 193():110119. PubMed ID: 38311030
[TBL] [Abstract][Full Text] [Related]
6. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
7. Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience.
Boyce-Fappiano D; Gjyshi O; Pezzi TA; Allen PK; Solimman M; Taku N; Bernstein MB; Cabanillas ME; Amini B; Tatsui CE; Rhines LD; Wang XA; Briere TM; Yeboa DN; Bishop AJ; Li J; Ghia AJ
J Neurosurg Spine; 2020 Feb; ():1-9. PubMed ID: 32059183
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine.
Folkert MR; Bilsky MH; Tom AK; Oh JH; Alektiar KM; Laufer I; Tap WD; Yamada Y
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1085-91. PubMed ID: 24661662
[TBL] [Abstract][Full Text] [Related]
9. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Radiosurgery for the Treatment of Primary and Metastatic Spinal Sarcomas.
Miller JA; Balagamwala EH; Angelov L; Suh JH; Djemil T; Magnelli A; Qi P; Zhuang T; Godley A; Chao ST
Technol Cancer Res Treat; 2017 Jun; 16(3):276-284. PubMed ID: 27074915
[TBL] [Abstract][Full Text] [Related]
11. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
[TBL] [Abstract][Full Text] [Related]
12. Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring.
Gjyshi O; Boyce-Fappiano D; Pezzi TA; Ludmir EB; Xiao L; Kaseb A; Amini B; Yeboa DN; Bishop AJ; Li J; Rhines LD; Tatsui CE; Briere TM; Ghia AJ
J Neurooncol; 2020 Jun; 148(2):327-334. PubMed ID: 32358642
[TBL] [Abstract][Full Text] [Related]
13. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
14. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.
Leeman JE; Bilsky M; Laufer I; Folkert MR; Taunk NK; Osborne JR; Arevalo-Perez J; Zatcky J; Alektiar KM; Yamada Y; Spratt DE
J Neurosurg Spine; 2016 Jul; 25(1):52-8. PubMed ID: 26943256
[TBL] [Abstract][Full Text] [Related]
16. Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation.
Chan MW; Thibault I; Atenafu EG; Yu E; John Cho BC; Letourneau D; Lee Y; Yee A; Fehlings MG; Sahgal A
J Neurosurg Spine; 2016 Apr; 24(4):652-9. PubMed ID: 26682603
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials.
Tao R; Bishop AJ; Brownlee Z; Allen PK; Settle SH; Chang EL; Wang X; Amini B; Tannir NM; Tatsui C; Rhines LD; Brown PD; Ghia AJ
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1405-1413. PubMed ID: 27209509
[TBL] [Abstract][Full Text] [Related]
19. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
[TBL] [Abstract][Full Text] [Related]
20. Pathological characteristics of spine metastases treated with high-dose single-fraction stereotactic radiosurgery.
Katsoulakis E; Laufer I; Bilsky M; Agaram NP; Lovelock M; Yamada Y
Neurosurg Focus; 2017 Jan; 42(1):E7. PubMed ID: 28041326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
